FDA Approved: * April 19, 2019
Pharm Company: * CUSTOPHARM INC
Category: Cancer

Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. It was originally launched as Valstar in the U.S. in 1999 for intravesical therapy of Bacille Calmette-Guérin (BCG)-refractory carcinoma in situ of the urinary bladder in patients in whom cystectomy would be associated with unacceptable... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Valrubicin Intravesical Solution Intravesical Solution 40 mg/ml Intravesical Solution, Concentrate
NDC: 24201-101
Leucadia Pharmaceuticals

Related Brands

Drugs with the same active ingredients